We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+2.9%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$4.5B
AUM Growth
-$40.1M
Cap. Flow
-$80.4M
Cap. Flow %
-1.79%
Top 10 Hldgs %
51.71%
Holding
90
New
6
Increased
21
Reduced
17
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 18.82%
2 Communication Services 18.79%
3 Consumer Discretionary 17.54%
4 Industrials 12.41%
5 Financials 7.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVTY icon
51
Revvity
RVTY
$12.8B
$2.66M 0.06%
53,700
+16,000
+42% +$764K
FMI
52
DELISTED
Foundation Medicine, Inc.
FMI
$2.33M 0.05%
128,000
+73,000
+133% +$1.18M
INCY icon
53
Incyte
INCY
$24.4B
$2.24M 0.05%
30,864
+15,000
+95% +$1.12M
ICLR icon
54
Icon
ICLR
$12.7B
$2.14M 0.05%
+28,500
New +$2M
JNJ icon
55
Johnson & Johnson
JNJ
$625B
$1.9M 0.04%
17,600
+6,000
+52% +$621K
IRWD icon
56
Ironwood Pharmaceuticals
IRWD
$714M
$1.89M 0.04%
206,562
+63,282
+44% +$522K
GRPN icon
57
Groupon
GRPN
$1.02B
$1.62M 0.04%
20,350
ARIA
58
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$1.6M 0.04%
250,300
+138,000
+123% +$773K
AERI
59
DELISTED
Aerie Pharmaceuticals
AERI
$1.48M 0.03%
122,000
BMRN icon
60
BioMarin Pharmaceuticals
BMRN
$12.4B
$1.42M 0.03%
17,220
PFE icon
61
Pfizer
PFE
$153B
$1.41M 0.03%
50,181
LIVN icon
62
LivaNova
LIVN
$4.2B
$1.29M 0.03%
23,982
ACAD icon
63
Acadia Pharmaceuticals
ACAD
$5.03B
$1.29M 0.03%
+46,000
New +$1M
CFMS
64
DELISTED
Conformis, Inc. Common Stock
CFMS
$1.2M 0.03%
+4,480
New +$1.19M
SGEN
65
DELISTED
Seagen Inc. Common Stock
SGEN
$1.19M 0.03%
34,000
CAH icon
66
Cardinal Health
CAH
$55.4B
$1.15M 0.03%
14,000
INFI
67
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.09M 0.02%
206,932
+60,000
+41% +$367K
VSTM icon
68
Verastem
VSTM
$610M
$1.09M 0.02%
57,410
BIIB icon
69
Biogen
BIIB
$30.7B
$1.04M 0.02%
4,000
-2,500
-38% -$660K
EMC
70
DELISTED
EMC CORPORATION
EMC
$1.01M 0.02%
38,000
MRK icon
71
Merck
MRK
$318B
$994K 0.02%
19,702
JUNO
72
DELISTED
Juno Therapeutics, Inc.
JUNO
$948K 0.02%
24,895
-15,105
-38% -$526K
RTX icon
73
RTX Corp
RTX
$301B
$800K 0.02%
12,712
-15,890
-56% -$922K
IMGN
74
DELISTED
Immunogen Inc
IMGN
$771K 0.02%
90,600
VECO icon
75
Veeco
VECO
$3.23B
$487K 0.01%
25,000

Similar funds

Platinum Investment Management's Q1 2016 Portfolio in Review

As of Q1 2016, Platinum Investment Management held 90 positions worth $4.5B, down 0.88% from $4.54B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Platinum Investment Management's Q1 2016 filing shows 6 new, 21 increased, 17 reduced and 10 closed positions. Its largest new stake was VanEck Gold Miners ETF: 4,149,000 shares worth $82.9M. The largest sale was YOUKU TUDOU INC.(CAYMAN ISLS), an estimated $116M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Platinum Investment Management's largest Q1 2016 buy was VanEck Gold Miners ETF: 4,149,000 shares worth $82.9M.
  • Platinum Investment Management added most to Gilead Sciences in Q1 2016, an estimated $78.5M increase.
  • Platinum Investment Management's biggest Q1 2016 reduction was Corning, cutting an estimated $97.6M.
  • Platinum Investment Management fully exited YOUKU TUDOU INC.(CAYMAN ISLS) in Q1 2016, selling an estimated $116M.
  • Platinum Investment Management's ten largest holdings make up 52% of its $4.5B portfolio in Q1 2016.
  • Platinum Investment Management opened 6 new positions and closed 10 in Q1 2016.
  • Platinum Investment Management's portfolio value fell 0.88% quarter-over-quarter to $4.5B.

Based on Platinum Investment Management's 13F filing for Q1 2016, filed 13 May 2016.